RECRUITING

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

Description

The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting

Study Overview

Study Details

Study overview

The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting

A Prospective Clinical Registry Evaluating Safety and Performance of Teleflex Vascular Access Devices

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

Condition
Vascular Access Device
Intervention / Treatment

-

Contacts and Locations

Huntsville

Huntsville Hospital, Huntsville, Alabama, United States, 35801

Loma Linda

Loma Linda University Health, Loma Linda, California, United States, 92354

Boston

Tufts Medical Center, Boston, Massachusetts, United States, 02111

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research.
  • * Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation.
  • * Subjects is able to read and understand English or Spanish languages
  • * Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry.
  • * Subject was previously failed screening or was enrolled in this clinical Registry.
  • * Subject is imprisoned
  • * Subject is cognitively impaired and unable to provide informed consent

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Teleflex,

Amy Bardin, STUDY_DIRECTOR, Teleflex Incorporated Clinical and Medical Affairs

Study Record Dates

2034-12-07